140 related articles for article (PubMed ID: 37454761)
21. Prevalence of human papillomavirus genotypes in cytologic abnormalities from unvaccinated women living in north-western Spain.
Otero-Motta AP; Ordóñez JL; González-Celador R; Rivas B; Macías Mdel C; Bullón A; Abad Mdel M
APMIS; 2011 Mar; 119(3):204-15. PubMed ID: 21284738
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China's top 3 hospital, 2009-2019.
Liu Y; Ang Q; Wu H; Xu J; Chen D; Zhao H; Liu H; Guo X; Gu Y; Qiu H
Virol J; 2020 Jul; 17(1):104. PubMed ID: 32660490
[TBL] [Abstract][Full Text] [Related]
23. Unusual and unique distribution of anal high-risk human papillomavirus (HR-HPV) among men who have sex with men living in the Central African Republic.
Mboumba Bouassa RS; Mbeko Simaleko M; Camengo SP; Mossoro-Kpinde CD; Veyer D; Matta M; Robin L; Longo JD; Grésenguet G; Péré H; Meye JF; Belec L
PLoS One; 2018; 13(5):e0197845. PubMed ID: 29795661
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and risk factors associated with high-risk human papillomavirus infection among women living with HIV (WLWH) at a tertiary health facility in Accra, Ghana.
Agyare Gyane F; Modey E; Maya E; Bonney EY; Abaidoo-Myles A; Paintsil E; Torpey K
PLoS One; 2024; 19(5):e0303535. PubMed ID: 38814956
[TBL] [Abstract][Full Text] [Related]
25. Detection and genotyping of HPV-DNA through different types of diagnostic platforms in liquid-based cervical-cytology samples.
Cassani B; Soldano G; Finocchiaro D; Conti S; Bulfamante A; Lemorini G; Bulfamante G
Pathologica; 2018 Dec; 110(4):294-301. PubMed ID: 30799441
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of high-risk human papillomavirus (HR-HPV) infection among women with normal and abnormal cervical cytology in Myanmar.
Mu-Mu-Shwe ; Harano T; Okada S; Aye-Aye-Win ; Khin-Saw-Aye ; Hlaing-Myat-Thu ; Mo-Mo-Win ; Khin-Khin-Oo ; Myo-Khin
Acta Med Okayama; 2014; 68(2):79-87. PubMed ID: 24743783
[TBL] [Abstract][Full Text] [Related]
27. Human papillomavirus infection in Rwanda at the moment of implementation of a national HPV vaccination programme.
Ngabo F; Franceschi S; Baussano I; Umulisa MC; Snijders PJ; Uyterlinde AM; Lazzarato F; Tenet V; Gatera M; Binagwaho A; Clifford GM
BMC Infect Dis; 2016 May; 16():225. PubMed ID: 27221238
[TBL] [Abstract][Full Text] [Related]
28. A retrospective analysis of human papillomavirus (HPV) prevalence and genotype distribution among 25,238 women in Shanghai, China revealed the limitations of current HPV-based screening and HPV vaccine.
Ruan Y; Li H; Liu M; Cao G; Xu X; Han L; Li F
Cancer Epidemiol; 2023 Jun; 84():102372. PubMed ID: 37119603
[TBL] [Abstract][Full Text] [Related]
29. HPV prevalence and genotype distribution in 2,306 patients with cervical squamous cell carcinoma in central and eastern China.
Han C; Huang W; Ye M; Zou R; Lan J; Chen J; Jiang J; Wang H; Xia L; Luo J; Li D; Geng J; Wang Z; Huang J
Front Public Health; 2023; 11():1225652. PubMed ID: 37701907
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of vaccine and non-vaccine human papillomavirus types among women in Accra and Kumasi, Ghana: a cross-sectional study.
Debrah O; Agyemang-Yeboah F; Donkoh ET; Asmah RH
BMC Womens Health; 2021 Oct; 21(1):372. PubMed ID: 34702246
[TBL] [Abstract][Full Text] [Related]
31. High-risk papillomavirus infection among women living with human Immunodeficiency virus: Brazilian multicentric study.
Miranda AE; Silveira MF; Travassos AG; Tenório T; Val ICC; Lannoy L; Mattos Junior HS; Carvalho NS
J Med Virol; 2017 Dec; 89(12):2217-2223. PubMed ID: 28771777
[TBL] [Abstract][Full Text] [Related]
32. Pre-vaccine era cervical human papillomavirus infection among screening population of women in west Austria.
Borena W; Grünberger M; Widschwendter A; Kraxner KH; Marth E; Mayr P; Meier J; Ruth N; Guerrero AT; Marth C; Holm-von Laer D
BMC Public Health; 2016 Aug; 16(1):889. PubMed ID: 27565569
[TBL] [Abstract][Full Text] [Related]
33. Human Papillomavirus infection and cervical lesions in HIV infected women on antiretroviral treatment in Thailand.
Delory T; Ngo-Giang-Huong N; Rangdaeng S; Chotivanich N; Limtrakul A; Putiyanun C; Suriyachai P; Matanasarawut W; Jarupanich T; Liampongsabuddhi P; Heard I; Jourdain G; Lallemant M; Le Coeur S;
J Infect; 2017 May; 74(5):501-511. PubMed ID: 28254419
[TBL] [Abstract][Full Text] [Related]
34. Pre-vaccination prevalence and genotype distribution of human papillomavirus infection among women from urban Tunis: a cross-sectional study.
Guettiti H; Ennaifer E; Attia L; Chelly D; Alaya NB; Aissa RB; Laassili T; Boubaker S
Asian Pac J Cancer Prev; 2014; 15(21):9361-5. PubMed ID: 25422225
[TBL] [Abstract][Full Text] [Related]
35. Rationale and design of a multicenter prospective cohort study for the eVALuation and monitoring of HPV infections and relATEd cervical diseases in high-risk women (VALHIDATE study).
Orlando G; Tanzi E; Chatenoud L; Gramegna M; Rizzardini G;
BMC Cancer; 2012 May; 12():204. PubMed ID: 22646512
[TBL] [Abstract][Full Text] [Related]
36. HPV types, cervical high-grade lesions and risk factors for oncogenic human papillomavirus infection among 3416 Tanzanian women.
Mchome BL; Kjaer SK; Manongi R; Swai P; Waldstroem M; Iftner T; Wu C; Mwaiselage J; Rasch V
Sex Transm Infect; 2021 Feb; 97(1):56-62. PubMed ID: 32269071
[TBL] [Abstract][Full Text] [Related]
37. High-risk human papillomavirus genotype distribution among women living with and at risk for HIV in Africa.
Chachage M; Parikh AP; Mahenge A; Bahemana E; Mnkai J; Mbuya W; Mcharo R; Maganga L; Mwamwaja J; Gervas R; Kibuuka H; Maswai J; Singoei V; Iroezindu M; Fasina A; Esber A; Dear N; Imbach M; Crowell TA; Hern J; Song X; Hoelscher M; Polyak CS; Ake JA; Geldmacher C;
AIDS; 2023 Mar; 37(4):625-635. PubMed ID: 36398743
[TBL] [Abstract][Full Text] [Related]
38. Age-specific prevalence of cervical human papillomavirus infection and cytological abnormalities in women in Gauteng Province, South Africa.
Richter K; Becker P; Horton A; Dreyer G
S Afr Med J; 2013 May; 103(5):313-7. PubMed ID: 23971121
[TBL] [Abstract][Full Text] [Related]
39. The association between human papillomavirus and cervical high-grade cytology among HIV-positive and HIV-negative Tanzanian women: A cross-sectional study.
Swai P; Kjaer SK; Mchome B; Manongi R; Msuya SE; Wu CS; Waldstrom M; Iftner T; Mwaiselage J; Rasch V
Acta Obstet Gynecol Scand; 2021 Apr; 100(4):775-785. PubMed ID: 33512002
[TBL] [Abstract][Full Text] [Related]
40. Human papillomavirus infection in HIV-1 infected women in Catalonia (Spain): implications for prevention of cervical cancer.
Stuardo V; Agustí C; Godinez JM; Montoliu A; Torné A; Tarrats A; Alcalde C; Martín D; Fernández-Montoli E; Vanrell C; Solé J; Canet Y; Marqueta JM; Mohamed J; Cuenca I; Lonca M; Sirera G; Ferrer E; Domingo P; Lloveras B; Miro JM; De Sanjosé S; Casabona J
PLoS One; 2012; 7(10):e47755. PubMed ID: 23118894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
